CGN Advisors LLC Sells 632 Shares of McKesson Corporation $MCK

CGN Advisors LLC decreased its holdings in shares of McKesson Corporation (NYSE:MCK) by 13.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,167 shares of the company’s stock after selling 632 shares during the period. CGN Advisors LLC’s holdings in McKesson were worth $3,418,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in MCK. GGM Financials LLC bought a new stake in shares of McKesson during the third quarter worth about $25,000. State of Wyoming bought a new position in McKesson in the 2nd quarter valued at about $29,000. Hopwood Financial Services Inc. bought a new position in McKesson in the 3rd quarter valued at about $31,000. Vermillion & White Wealth Management Group LLC acquired a new position in McKesson during the 3rd quarter valued at about $33,000. Finally, Abound Wealth Management increased its holdings in McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after purchasing an additional 24 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Wells Fargo & Company raised their target price on McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Zacks Research lowered shares of McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Leerink Partners reissued an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. TD Cowen increased their price target on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Finally, Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, March 14th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $960.93.

McKesson Trading Down 2.3%

Shares of McKesson stock opened at $898.82 on Friday. The company’s 50-day moving average price is $902.24 and its 200-day moving average price is $831.10. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00. The company has a market cap of $110.10 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 1.48 and a beta of 0.38.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter in the prior year, the firm posted $8.03 earnings per share. The business’s quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts predict that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s payout ratio is presently 9.43%.

Insider Buying and Selling

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Maria Martinez sold 349 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the transaction, the director owned 301 shares of the company’s stock, valued at $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 3,868 shares of company stock valued at $3,743,820 in the last 90 days. 0.08% of the stock is owned by company insiders.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.